The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.00
Ask: 3.30
Change: 0.025 (0.80%)
Spread: 0.30 (10.00%)
Open: 3.125
High: 3.15
Low: 3.00
Prev. Close: 3.125
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

18 Mar 2019 09:05

RNS Number : 1584T
Allergy Therapeutics PLC
18 March 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMGGUAUWUPBUBR
Date   Source Headline
23rd May 201211:23 amRNSVoluntary recall of Anapen by Lincoln Medical
17th May 20124:51 pmRNSHolding(s) in Company
17th May 20124:51 pmRNSHolding(s) in Company
16th May 201211:11 amRNSTotal Voting Rights
2nd May 20123:33 pmRNSBoard Appointment
24th Apr 201212:31 pmRNSHolding(s) in Company
20th Apr 20128:01 amRNSConcert Party Shareholding
20th Apr 20128:01 amRNSDirector/PDMR Shareholding
19th Apr 20123:05 pmRNSResult of AGM
18th Apr 20127:00 amRNSResult of Offer
30th Mar 20127:02 amRNSGrant of Options
30th Mar 20127:01 amRNSFundraising Announcement
30th Mar 20127:00 amRNSHalf Yearly Report
14th Mar 20129:23 amRNSNotice of results and shareholder update
21st Feb 20126:12 pmRNSHolding(s) in Company
21st Feb 20126:11 pmRNSHolding(s) in Company
6th Dec 20117:00 amRNSAnapen® 500mcg epinephrine auto-injector
28th Nov 20117:00 amRNSRegulatory update PEI FDA
16th Nov 20115:20 pmRNSAGM Statement
20th Oct 20116:24 pmRNSAnnual Financial Report
29th Sep 201112:45 pmRNSProvisional Grant of Options
19th Sep 20117:00 amRNSFinal Results
19th Sep 20117:00 amRNSDistribution Agreement
8th Sep 20115:06 pmRNSHolding(s) in Company
7th Sep 20117:00 amRNSNotice of Results
23rd Aug 20119:35 amRNSForm 8.3 - [Allergy Therapeutics]
23rd Aug 20117:00 amRNSAllergy Therapeutics enters Latin America
22nd Aug 201112:03 pmRNSForm 8.3 - [Allergy Therapeutics Plc]
8th Jun 20117:00 amRNSRegulatory Update
28th Apr 20117:00 amRNSTotal Voting Rights
26th Apr 20117:00 amRNSFDA Update
20th Apr 20112:59 pmRNSExercise of Options
11th Apr 20114:31 pmRNSHolding(s) in Company
7th Apr 20117:00 amRNSGrass MATA MPL dossier submitted in Switzerland
30th Mar 20116:19 pmRNSDirector/PDMR Shareholding
29th Mar 20113:19 pmRNSDirector/PDMR Shareholding
29th Mar 20113:17 pmRNSDirector/PDMR Shareholding
28th Mar 20117:02 amRNSU.S. regulatory update
28th Mar 20117:00 amRNSHalf Yearly Report
9th Feb 201110:32 amRNSHolding(s) in Company
9th Feb 201110:31 amRNSHolding(s) in Company
1st Dec 20107:00 amRNSTen further MAAs submitted in Germany
18th Nov 201011:52 amRNSResult of AGM
20th Oct 20108:06 amRNSAnnual Financial Report
4th Oct 20109:45 amRNSDirector/PDMR Shareholding
30th Sep 20103:21 pmRNSDirectorate Change
20th Sep 20107:00 amRNSFinal Results
26th Jul 201010:06 amRNSHolding(s) in Company
22nd Jul 201012:24 pmRNSTrading Statement
19th Jul 201012:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.